Guest guest Posted July 13, 2009 Report Share Posted July 13, 2009 Statins are derived from molds. I have often seen individuals exposed to water damaged buildings who have elevated cholesterol. Also, the elevation occurs in individuals with metabolic syndrome from exposure to xenobiotics. The message is clear, be careful of Statins. http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2704421 & blobtype=pdf 1: CMAJ. 2009 Jul 7;181(1-2):E11-8. Association between statin-associated myopathy and skeletal muscle damage. Mohaupt MG, Karas RH, Babiychuk EB, -Freire V, Monastyrskaya K, Iyer L, Hoppeler H, Breil F, Draeger A. Department of Nephrology and Hypertension, Inselspital, University of Bern, Bern, Switzerland. BACKGROUND: Many patients taking statins often complain of muscle pain and weakness. The extent to which muscle pain reflects muscle injury is unknown. METHODS: We obtained biopsy samples from the vastus lateralis muscle of 83 patients. Of the 44 patients with clinically diagnosed statin-associated myopathy, 29 were currently taking a statin, and 15 had discontinued statin therapy before the biopsy (minimal duration of discontinuation 3 weeks). We also included 19 patients who were taking statins and had no myopathy, and 20 patients who had never taken statins and had no myopathy. We classified the muscles as injured if 2% or more of the muscle fibres in a biopsy sample showed damage. Using reverse transcriptase polymerase chain reaction, we evaluated the expression levels of candidate genes potentially related to myocyte injury. RESULTS: Muscle injury was observed in 25 (of 44) patients with myopathy and in 1 patient without myopathy. Only 1 patient with structural injury had a circulating level of creatine phosphokinase that was elevated more than 1950 U/L (10x the upper limit of normal). Expression of ryanodine receptor 3 was significantly upregulated in patients with biopsy evidence of structural damage (1.7, standard error of the mean 0.3). INTERPRETATION: Persistent myopathy in patients taking statins reflects structural muscle damage. A lack of elevated levels of circulating creatine phosphokinase does not rule out structural muscle injury. Upregulation of the expression of ryanodine receptor 3 is suggestive of an intracellular calcium leak. Jack D. Thrasher, Ph.D. Toxicologist/Immunotoxicologist/Fetaltoxicologist www.drthrasher.org toxicologist1@... Off: 916-745-4703 Cell: 575-937-1150 L. Crawley, M.ED., LADC Trauma Specialist sandracrawley@... 916-745-4703 - Off 775-309-3994 - Cell This message and any attachments forwarded with it is to be considered privileged and confidential. The forwarding or redistribution of this message (and any attachments) without my prior written consent is strictly prohibited and may violate privacy laws. Once the intended purpose of this message has been served, please destroy the original message contents. If you have received this message in error, please reply immediately to advise the sender of the miscommunication and then delete the message and any copies you have printed. Thank you in advance for your compliance. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.